Zilver Ptx
Payments companies reported to CMS as associated with Zilver Ptx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zilver Ptx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zilver Ptx
These are the largest totals companies reported as associated with Zilver Ptx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Wilderman | Hackensack, NJ | Vascular Surgery | $56,476.61 |
| Charles Bailey | Tampa, FL | Vascular Surgery | $30,379.94 |
| George Adams | Garner, NC | Interventional Cardiology | $29,747.68 |
| Arthur Lee | Gainesville, FL | Interventional Cardiology | $26,494.02 |
| John Phillips | Columbus, OH | Interventional Cardiology | $20,777.34 |
| Dejah Judelson | Worcester, MA | Vascular Surgery | $14,541.07 |
| Jean Bismuth | Houston, TX | Vascular Surgery | $13,826.93 |
| Sreekumar Madassery | Chicago, IL | Vascular & Interventional Radiology | $11,991.21 |
| Constantino Pena | Miami, FL | Diagnostic Radiology | $11,885.17 |
| Jeffrey Crawford | Corvallis, OR | Vascular Surgery | $11,883.25 |
Prescribed Zilver Ptx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.